Gefitinib

Gefitinib helps to relieve the extreme pain and discomfort suffered by patients of breast or lung cancers. It slows down the production of cancer cells, thereby inhibiting the spread of the malignant tissues. It can be administered orally with or without food.

The dosage depends upon the medical history of the patient, health conditions and the response to the therapy.

The drug is contraindicated in patients who have suffered or are suffering from glaucoma, cardiac disorders, lungs or liver disorders or renal malfunctioning. Take proper medical help in case you are pregnant, planning a pregnancy any time soon or breastfeeding. You must also inform the doctor of any other prescription drugs that you may be taking, such as hormonal pills as oral contraceptives, or any dietary supplements as Gefitinib may interact with the other drugs and cause a number of health complications. You must avoid alcohol consumption, smoking, tobacco or caffeine during the course of the treatment to avoid any further health complications. There may be a number of side effects such as headaches, blurred vision, some nausea, and some allergic rashes on the skin. However there can be some adverse reactions as well. It is advised that even the slightest discomfort should be reported to the doctor immediately, in order to avoid complications.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Small Cell Lung Cancer

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Nausea

• Rash

• Vomiting

• Weakness

• Loss Of Appetite

• Dry Skin

• Diarrhoea

• Stomatitis (Inflammation Of The Mouth)

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Is It safe with alcohol?

  Interaction with alcohol is unknown. Please consult your doctor.

• Are there any pregnancy warnings?

  Emfib 250mg tablet is unsafe to use during pregnancy.
  There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.

• Are there any breast-feeding warnings?

  Emfib 250mg tablet is probably unsafe to use during breastfeeding. Please consult your doctor.

• Is it safe to drive while on this medicine?

  Patients may experience undesirable effects like asthenia and should avoid driving vehicles or using machines.

• Does this affect kidney function?

  There is no interaction between renal impairment and consuming this drug. So dose alteration is not needed.

• Does this affect liver function?

  There is no data available. Please consult doctor before consuming the drug.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

Below is the list of medicines, which contains Gefitinib as ingredient

• Chemofit 250Mg Tablet

  RPG Life Sciences Ltd

• Grexam 250Mg Tablet

  Sun Pharmaceutical Industries Ltd

• Geftiglan 250Mg Tablet

  Gland Pharma Limited

• Geftifos 250Mg Tablet

  Torrent Pharmaceuticals Ltd

• Xefta 250Mg Tablet

  Dr Reddy s Laboratories Ltd

• Tyrogef 250Mg Tablet

  Sun Pharmaceutical Industries Ltd

• Geficad 250mg Tablet

  Cadila Pharmaceuticals Ltd

• Zufinib 250Mg Tablet

  Zuventus Healthcare Ltd

• Geftinat 250Mg Tablet

  Natco Pharma Ltd

• Geftilon 250Mg Tablet

  Celon Laboratories Ltd

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

Gefitinib is an anticancer agent which binds to the ATP binding site of the enzyme tyrosine kinase, an epidermal growth factor receptor (EGFR). This inhibits tyrosine kinase and prevents activation of Ras signal transduction cascade, preventing growth of malignant cells.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.